Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I can understand the write off, the value for shareholders has absolutely been ravaged over time. The continued delays regarding USA does nothing but frustrate, how long are you anticipating for the success Bothwell? I feel it could still be another year or more till FDA developments
Yes bignose the information looks very encouraging when looked at like that. my concern is why is it taken so long to get anything over the line if it has such massive potential ? Surely we are valued extremely cheaply right now to the sort of companies who would be in the market for a product of the nature you would believe from reading those reports . I live in continued hope this can reward us all eventually and it will play out successfully !
What news are we due from fda by end of March ?
Not long to wait bothwell? How do we know this though, it’s been delay after delay . I was expecting this to be done years ago and now we still hang on
I have never understood why the DLI was added, it would make sense if it added an immediate income stream in some way but it doesn’t appear to be adding much in the slightest , I have seen in announcements talk of insurance companies etc but no solid income generation as yet .
In regards to US and China, that seems to be all that anyone here is holding out for . I have tried to connect the dots regarding strategy with all the other license agreements that have been signed off .. would USA developments bring a similar license deal on a much larger scale or something else ? We live in hope
Great question Keith , I would love to know what is happening behind the scenes where compensation of over a million is justified for the management of the organisation , for that sort of salary some real value should be being added to the company but the valuation has drifted down endlessly .
They must be upto something like this behind the scenes , there must be a left field tactic they are going after . Hopefully sooner rather than later it is realised . There has been enough data to show the product is safe and effective .
What’s your thoughts on future time frames now we into 2021 guys ? USA progress must be due shortly , I mean shortly by endurance timeframes so within months , not years . Thought we would of got more clarity about plan moving forward regarding the most recent update we got also
thanks guys for the feedback, I just took that the article was all about live sports betting but maybe my mistake. hopefully you are right and one of the big dogs want to gobble up leap!!
Leap is not a bookmakers. That whole article is about sports betting …
$1+ Heimdel? been waiting for that for years now and what’s the signs it could change soon?
Only a meagre 700% rise needed to get us there
Can anyone offer any explanation about what this update means for the plans moving forward and the reasoning for these new meeting requests ?Would be great to have some clarification instead of the usual wishing that one day that things turn around for the better
Could this be a plan to achieve commercialisation and get the product to market in America quicker and with less data and time needed ? Maybe due to previous eu trials they can use those results to help achieve this . Just my uneducated take on the matter
Totally agree Italian, it has baffled me . Could do with some clarity on the situation
Heimdel do you have a link for this Swedish pharma directors interview ? Would be interesting to hear this point of view
Much needed now , still sliding daily . Surely we are due an update on what’s going on with fda , it seems to have gone a long time with no updates regarding how it’s progressing/ if it is!
just stumbled across an article from 2018 from Investors Chronicle writer Simon Thompson in regard to Regent Pacific.
" Jones long lasalle determined fair value of PSD502 to be in the region of £167M".
Here we are sitting at market cap of around £35 m with say £10m attributed to Venturex resources( Now Develop global)...so say around £25m for psd502....we can maybe agree on disappointments regarding timeframes and operation progress but just maybe we are massively under valued at the same time.
Very true bothwell , I hadn’t thought about how the name change could be relevant. There has been nothing to show of its purpose as of yet, hopefully there is something exciting brewing that was the reason for the name change . Hope continues
the slide continues.. we really need something to kick start momentum here as its a the same old cycle it appears. never had any clarity as to how the DLI is being commercialised to make money, only hope is positive action is happening behind the scenes which may well be wishful thinking.
Agreed Italian! It just goes on and on with silence and no updates . Hopefully things are happening behind the scenes that are adding value here but we have thought that before time and time again .